Hydrix Limited (ASX:HYD) has raised capital via a placement
Hydrix Limited has completed a capital raise with institutional and sophisticated investors. The capital will be used to bolster the company’s growth strategy and to extinguish outstanding secured debt.
Hydrix is a product innovation company providing product development services for clients in large addressable global markets, including medical and industrial, and connected cardiovascular technologies and services throughout the Asia Pacific region. With over 200 successfully designed products and solutions, Hydrix is recognized as one of the leading product development companies in Australia. It has three core business segments: services, medical and ventures. The company is underpinned by world-class product development expertise within Hydris Services and is now leveraging these skill sets to create and capture the value that it creates for its customers via Hydrix Medical and Hydrix Ventures.
Oaklins’ team in Australia acted as co-manager in this transaction.
Talk to the deal team
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreOmer Engineering has completed an IPO
Omer Engineering Ltd. has successfully launched its IPO on the Tel Aviv Stock Exchange, pricing shares as part of a plan to raise approximately US$94 million at an implied pre-money valuation of around US$313 million. The offering included both newly issued shares and a secondary sale by existing shareholders, who retained a significant majority stake post-IPO. This transaction underscores strong investor interest in scaling the company’s operations and enhancing its capital.
Learn moreSmart Capital has finalized a rights issue
Smart Capital S.p.A. has finalized a rights issue to continue executing its growth plan and increase its investment capacity. The fundraising supports the expansion of its investment portfolio and the strengthening of its positions in higher-quality investee companies with stronger growth prospects.
Learn more